DRUG FOR TREATING FATTY LIVER AND NON-ALCOHOLIC STEATOHEPATITIS

The present inventors have discovered that a peptide derived from HMGB 1 can be used as a therapeutic and/or preventive agent for fatty liver, nonalcoholic steatohepatitis, and various symptoms accompanied by the fatty liver. On the basis of this discovery, the present application provides a use of...

Full description

Saved in:
Bibliographic Details
Main Authors YAMAZAKI, Takehiko, TAMAI, Katsuto, TSUCHIYA, Atsunori, SHIMBO, Takashi, TERAI, Shuji
Format Patent
LanguageEnglish
French
German
Published 07.08.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present inventors have discovered that a peptide derived from HMGB 1 can be used as a therapeutic and/or preventive agent for fatty liver, nonalcoholic steatohepatitis, and various symptoms accompanied by the fatty liver. On the basis of this discovery, the present application provides a use of the peptide derived from HMGB 1 which is different from conventional uses.
Bibliography:Application Number: EP20220876529